BeOne Medicines
ONC
#647
Rank
C$54.93 B
Marketcap
C$485.65
Share price
0.46%
Change (1 day)
6.39%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$6.65

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$6.71. In 2025 the company made an earnings per share (EPS) of C$3.81 an increase over its 2024 EPS that were of C-$8.71.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$6.6574.56%
2025C$3.81-143.75%
2024C-$8.71
2022C-$27.2128.21%
2021C-$21.22-19.96%
2020C-$26.5120.81%
2019C-$21.9531.52%
2018C-$16.69417.57%
2017C-$3.22-37.16%
2016C-$5.13158.95%
2015C-$1.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.38-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.33-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA